Minor Protease Inhibitor Mutations at Baseline Do Not Increase the Risk for a Virological Failure in HIV-1 Subtype B Infected Patients

BACKGROUND: Minor protease inhibitor (PI) mutations often exist as polymorphisms in HIV-1 sequences from treatment-naïve patients. Previous studies showed that their presence impairs the antiretroviral treatment (ART) response. Evaluating these findings in a larger cohort is essential. METHODS: To s...

Descripción completa

Detalles Bibliográficos
Autores principales: Scherrer, Alexandra U., Ledergerber, Bruno, von Wyl, Viktor, Böni, Jürg, Yerly, Sabine, Klimkait, Thomas, Cellerai, Cristina, Furrer, Hansjakob, Calmy, Alexandra, Cavassini, Matthias, Elzi, Luigia, Vernazza, Pietro L., Bernasconi, Enos, Günthard, Huldrych F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377720/
https://www.ncbi.nlm.nih.gov/pubmed/22719859
http://dx.doi.org/10.1371/journal.pone.0037983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377720/
https://www.ncbi.nlm.nih.gov/pubmed/22719859
http://dx.doi.org/10.1371/journal.pone.0037983

Ejemplares similares